Orchestra BioMed Holdings, Inc.
Status: Publicly traded
Direct answer
Orchestra BioMed Holdings, Inc. is publicly traded on NASDAQ under the ticker OBIO.
Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive...
Can you invest in Orchestra BioMed Holdings, Inc.?
Yes. Orchestra BioMed Holdings, Inc. is publicly traded on NASDAQ under the ticker OBIO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Orchestra BioMed Holdings, Inc.
Detailed equity research is provided by MarketSnap.